Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Diabetes and Its Complications|August 30, 2002
Determinants and estimation of healing times in diabetic foot ulcersStefan Zimny, Helmut Schatz, Martin Pfohl
Diabetes Care|March 30, 2004
The role of limited joint mobility in diabetic patients with an at-risk footStefan Zimny, Helmut Schatz, Martin Pfohl
Cardiovascular and Interventional Radiology|October 9, 2007
Embolization of an insulinoma of the pancreas with trisacryl gelatin microspheres as definitive treatmentGernot Rott, Martin Biggemann, Martin Pfohl
Endocrine Reviews|February 15, 2002
Changes in proinflammatory cytokine activity after menopauseJohannes Pfeilschifter, Roland Köditz, Martin Pfohl, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 13, 2010
Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitusSatish Garg, Francisco Javier Ampudia-Blasco, Martin Pfohl
Medizinische Klinik (Munich, Germany : 1983)|February 26, 2003
[Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients]Bernadette Reinsch, Stefan Zimmy, Helmut Schatz, et al.
Vascular Health and Risk Management|November 26, 2015
Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational studyMartin Pfohl, Thorsten Siegmund, Stefan Pscherer, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2019
Austrian Experience with Lixisenatide Under Real-Life Conditions: A Prospective Observational StudyHelmut Brath, Heidemarie Abrahamian, Tvrtko Karuza, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 5, 2021
Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S StudyJochen Seufert, Martin Pfohl, Anja Borck, et al.
Diabetes, Obesity & Metabolism|January 6, 2025
Effectiveness and safety of iGlarLixi in people with type 2 diabetes not at target on basal insulin and oral antidiabetic therapy in a prospective observational trialJochen Seufert, Tobias Wiesner, Katrin Pegelow, et al.
Pageof 3